What’s New in the Management of Advanced Skin Cancer

April 7, 2025

Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) are the most common types of advanced/non-melanoma skin cancers. Listen in as Todd Schlesinger, MD, FAAD shares with listeners updates in managing these types of cancers including systemic therapies and mitigating adverse events.

Summary

Availability:

On-Demand

Expires on Apr 07, 2028

Credit Offered:

0.5 CME Credit

Recommended

High-Yield Updates on Management of Bread N' Butter Dermatologic Diseases

August 4, 2025

New treatments raise excitement in the field of dermatology, but they also lead to learning curves to optimize patient care. Listen as Erin Wei, MD, FAAD and Shawna Flanagan, MD, FAAD discusses High-Yield Updates on Management of Bread N’ Butter Dermatologic Diseases including the latest therapies and safety profiles, chemoprevention, and clinical pathology pearls.

0.5 CME

Question of the Week Self-Assessment - 2026

13.25 CME

Complex Medical Dermatology Cases: Pearls and Pitfalls

August 25, 2025

Complex medical dermatology exhibits unique challenges that demand tailored precision, adaptability, and collaboration with other medical specialists. Listen as Christina Lam, MD, FAAD and Casey Carlos, MD, PhD, FAAD consider how evolving therapies and tools are reframing care for patients with multifaceted skin disease.

0.5 CME

Vitiligo

September 8, 2025

Recent developments in treatment for vitiligo are redefining what long-term management and re-pigmentation can look like. Listen as David Rosmarin, MD, FAAD and Olayemi Sokumbi, MD, FAAD discuss how these new therapies are reshaping long-term outcomes and expectations for patients and physicians alike.

0.5 CME

The Evolving Toolbox for Treating Difficult Warts

November 3, 2025

Despite their common condition, warts are often stubborn to the most routine care. On this episode, Peter Friedman, MD, FAAD and Hillary Johnson-Jahangir, MD, PhD, FAAD highlight how today’s therapeutic toolbox is giving dermatologists fresh options for treatment.

0.5 CME

Practical Considerations for Systemic Treatment of Atopic Dermatitis in Adults

September 15, 2025

Systemic treatments are transforming what patients with atopic dermatitis can expect from care. Listen as Aaron Drucker, MD, FAAD and Deirdre Hooper, MD, FAAD discuss how new treatments outside of topicals and light therapy are improving its management and outcomes.

0.5 CME

Regenerative Treatment for Hair

August 18, 2025

Cosmetic dermatology, specifically for hair loss and restoration, has shifted it’s focus to subtle, more natural results. On this episode, Neil Sadick, MD, FAAD and Sanna Ronkainen, MD discuss how emerging in-office and at-home treatments are transforming outcomes for patients seeking to slow the progression of hair thinning and aging.

0.5 CME

Untangling the mystery of central centrifugal cicatricial alopecia: What new research insights have taught us (July JAAD)

September 1, 2025

Once believed to be derived from poor hairstyling practices, Josee Smith, MD and Crystal Aguh, MD, FAAD discuss the complex mystery of central centrifugal cicatricial alopecia, or CCCA. Learn more about new treatments and proper diagnosis to provide you patients with a better outcome from this scarring condition.

0.5 CME

Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL 2 study (June JAAD)

July 14, 2025

Generalized pustular psoriasis is an inflammatory skin condition that can lead to serious complications such as sepsis and cardiovascular failure if left untreated. Join Alice B. Gottlieb, MD, PhD and Sanna Ronkainen, MD, FAAD as they discuss the latest JAAD article and research study results highlighting the efficacy of spesolimab and other biologics to consider to treat this disorder.

0.5 CME

Measles Resurgence: What Every Dermatologist Should Know (September JAAD)

November 10, 2025

Measles was once a disease of the past, but recent outbreaks hint at its return. Listen as Esther Freeman, MD, PhD, FAAD and Benjamin Stoff, MD, FAAD explore the factors behind its resurgence and the renewed importance of vigilance in clinical practice.

0.5 CME